Navigate
RSS FeedHome » Making Sense of FDA's Risk-Based Initiative
Making Sense of FDA's Risk-Based Initiative
Print pageOverview:
Here's a no-nonsense three-page overview of FDA's 21st Century cGMP guidelines, written by attorney Patricia J. Kaeding, formerly of FDA's Office of Chief Counsel.
More content on this topic:
- Featured White Papers